Financials SpineGuard

Equities

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:35:13 2024-04-26 EDT 5-day change 1st Jan Change
0.2235 EUR -2.83% Intraday chart for SpineGuard -6.29% +11.97%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 18.71 5.146 1.948 23.23 33.69 18.41
Enterprise Value (EV) 1 23.81 10.42 6.745 27.79 33.28 18.34
P/E ratio -4.45 x -2.08 x -3.28 x -9.29 x -18 x -7.26 x
Yield - - - - - -
Capitalization / Revenue 2.29 x 0.68 x 0.29 x 4.79 x 7.65 x 3.29 x
EV / Revenue 2.91 x 1.38 x 0.99 x 5.73 x 7.56 x 3.27 x
EV / EBITDA -9.86 x -10.9 x -32.7 x -33.2 x -29.7 x -12.9 x
EV / FCF -17.8 x -10.6 x -19.7 x 493 x -36.8 x -12.3 x
FCF Yield -5.61% -9.45% -5.08% 0.2% -2.72% -8.14%
Price to Book -91.7 x -10.7 x 5.29 x -3,421 x 6.67 x 3.75 x
Nbr of stocks (in thousands) 5,584 6,700 8,049 17,867 29,710 31,714
Reference price 2 3.350 0.7680 0.2420 1.300 1.134 0.5805
Announcement Date 18-03-15 19-03-15 20-03-20 21-04-28 22-04-29 23-04-18
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 8.174 7.575 6.829 4.852 4.405 5.6
EBITDA 1 -2.414 -0.9594 -0.2065 -0.836 -1.119 -1.418
EBIT 1 -2.547 -1.073 -0.3114 -0.961 -1.239 -1.526
Operating Margin -31.15% -14.16% -4.56% -19.81% -28.12% -27.26%
Earnings before Tax (EBT) 1 -4.125 -2.315 -1.075 -2.68 -1.649 -2.089
Net income 1 -4.125 -2.334 -0.6857 -2.716 -1.725 -2.393
Net margin -50.47% -30.81% -10.04% -55.99% -39.15% -42.74%
EPS 2 -0.7525 -0.3700 -0.0737 -0.1400 -0.0631 -0.0800
Free Cash Flow 1 -1.336 -0.984 -0.3427 0.0564 -0.9044 -1.492
FCF margin -16.34% -12.99% -5.02% 1.16% -20.53% -26.65%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-03-15 19-03-15 20-03-20 21-04-28 22-04-29 23-04-18
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 5.1 5.27 4.8 4.56 - -
Net Cash position 1 - - - - 0.41 0.07
Leverage (Debt/EBITDA) -2.113 x -5.495 x -23.23 x -5.459 x - -
Free Cash Flow 1 -1.34 -0.98 -0.34 0.06 -0.9 -1.49
ROE (net income / shareholders' equity) -841% 669% -1,338% -932% -68.4% -47%
ROA (Net income/ Total Assets) -18.1% -8.38% -2.38% -7.26% -7.76% -8.15%
Assets 1 22.76 27.87 28.81 37.44 22.23 29.36
Book Value Per Share 2 -0.0400 -0.0700 0.0500 -0 0.1700 0.1500
Cash Flow per Share 2 0.2100 0.1600 0.1100 0.0500 0.1800 0.1200
Capex 1 0.04 0.05 0.08 0.05 0.04 0.03
Capex / Sales 0.52% 0.63% 1.13% 1% 0.87% 0.61%
Announcement Date 18-03-15 19-03-15 20-03-20 21-04-28 22-04-29 23-04-18
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA